Press Releases
1.08.2013
Adimab Expands Collaborations with Merck and Lilly
> download PDF
1.07.2013
Adimab Announces New Discovery Collaboration with Kyowa Hakko Kirin
> download PDF
8.01.2012
Adimab and Mersana Announce Antibody-Drug Conjugate Alliance
> download PDF
4.19.2012
Adimab Announces New Antibody Discovery Program with Gilead and Initiates First Bispecific Antibody Collaboration
> download PDF
4.02.2012
Adimab Completes Series F Financing – Acquires New Research Facility to Accommodate Growth
> download PDF
1.11.2012
Three Adimab Antibodies Enter Human Clinical Trials
> download PDF
1.05.2012
Adimab Expands Executive Team with Addition of Philip T. Chase as General Counsel
Guy Van Meter Promoted to Vice President of Business Development
> download PDF
8.29.2011
Adimab Announces New Discovery Programs with Biogen Idec and Novo Nordisk
> download PDF
12.15.2010
Adimab Announces New Discovery Programs with Eli Lilly, Genentech and Human Genome Sciences
> download PDF
09.15.2010
Adimab makes FierceBiotech’s “Fierce 15″ List for 2010
> download PDF
09.01.2010
Adimab Selected as Technology Pioneer 2011 by World Economic Forum
> download PDF
07.09.2010
Adimab Announces Fifth Major Pharmaceutical Partnership in First Year After Launch of Novel Antibody Discovery Platform
> download PDF
12.17.2009
Adimab Announces New Antibody Discovery Collaborations with Pfizer and an Unnamed Partner and Achievement of Milestones in Existing Partnerships with Roche and Merck
> download PDF
10.01.2009
Adimab Completes Series D Financing Led by Google Ventures
> download PDF
6.16.2009
Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche
> download PDF
11.20.2008
Adimab, Inc. Announces Series C Financing
> download PDF
10.24.2008
Guy Van Meter joins Adimab, Inc. as Senior Director, Head of Business Development
> download PDF
05.28.2008
Adimab, Inc expands Scientific Advisory Board with Dr. Sachdev Sidhu
> download PDF
03.25.2008
Adimab, Inc. announces Series B Financing – Polaris and SV Life Sciences co-lead the investment
> download PDF
02.04.2008
Piotr Bobrowicz, Ph.D. to join Adimab, Inc. as Associate Director of Strain Development
> download PDF
11.01.2007
Adimab Annouces Scientific Advisory Board members
> download PDF
09.17.2007
Adimab and DNA2.0 Enter Exclusive Antibody Discovery Relationship
> download PDF
07.26.2007
Adimab Acquires Rights to Genetastix Yeast Antibody Patents
> download PDF
07.20.2007
Adimab, Inc. Secures Series A Financing from Polaris and SV Life Sciences
> download PDF
07.09.2007
Max Vásquez Ph.D. joins Adimab as Senior Director of Computational Biology
> download PDF
News Articles
Scrip Intelligence
> Adimab’s Gerngross seeks two sweethearts
The Pink Sheet
> Adimab Inks Novo, Biogen Deals, On Track to Double Partnered Programs for Second Straight Year
Xconomy
> Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners
BioWorld Today
> Adimab Signs Novartis in Fifth Antibody Deal
Xconomy
> Novartis Test Drives Adimab’s Drug Discovery Engine
BioWorld Today
> Adimab’s Yeast-Based Antibody Platform Nabs Two More Deals
The In Vivo Blog
> For Adimab, Deals and Deal Milestone Payments Come in Twos
Xconomy
> Adimab Proves Fast Antibody Discovery Tool to Merck, Roche; Snags New Deal With Pfizer
Chemical & Engineering News
> Practical Platform
BioWorld Today
> Adimab Yeast-Based Platform Draws Big Pharma’s Attention
The In Vivo Blog
> Adimab Banks on the Value of Discovery
Xconomy
> Adimab Strikes Antibody-Discovery Deals with Merck and Roche
The In Vivo Blog
> Notes from BIO: Adimab Pulls Back the Curtain
BioCentury
> Adimab: Simplifying the antibody recipe
The In Vivo Blog
> Adimab gets backed by Polaris and SVLS
VentureBeat
> Adimab: A potential one-stop shop for antibodies